• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏疾病中接触因子的凝血活性和抗原浓度

Clotting activities and antigen concentrations of contact factors in kidney disease.

作者信息

Mannhalter C, Deutsch E, Kopsa H

出版信息

Thromb Res. 1985 Aug 15;39(4):475-84. doi: 10.1016/0049-3848(85)90171-9.

DOI:10.1016/0049-3848(85)90171-9
PMID:3850648
Abstract

Factor XII, prekallikrein (PK) and high molecular weight kininogen (HMWK) clotting activities and antigen concentrations in kidney disease patients were studied. Chronic hemodialysis led to a reduction of F XII, PK and HMWK clotting activities. F XII and PK antigen levels were also low. In contrast, the HMWK antigen was normal with respect to concentration as well as electrophoretic migration behaviour on 2 D-immunelectrophoresis. In kidney transplant recipients more than three month after the transplantation, we found an increased of F XII and PK clotting activities, which appeared to depend on the time elapsed since the operation. However, the antigen levels remained normal. The group of chronic kidney disease patients not requiring hemodialysis exhibited normal mean values of all three clotting activities as well as normal F XII and HMWK antigen levels. The PK antigen was reduced. However, a separate evaluation of F XII clotting activities (F XII:C) in patients with glomerular nephritis showed elevated F XII:C which correlated with the BUN values. During acute processes of the kidney disease we observed very high PK clotting activities, which normalized with stabilization of the patients. Our results show that the contact phase coagulation factors behave abnormally in certain kidney disease patients.

摘要

我们研究了肾病患者中凝血因子 XII、前激肽释放酶(PK)和高分子量激肽原(HMWK)的凝血活性及抗原浓度。慢性血液透析导致凝血因子 XII、PK 和 HMWK 的凝血活性降低。凝血因子 XII 和 PK 的抗原水平也较低。相比之下,HMWK 的抗原在浓度以及二维免疫电泳上的电泳迁移行为方面均正常。在肾移植受者术后三个月以上,我们发现凝血因子 XII 和 PK 的凝血活性增加,这似乎取决于手术之后经过的时间。然而,抗原水平仍保持正常。不需要进行血液透析的慢性肾病患者组,所有三项凝血活性的平均值以及凝血因子 XII 和 HMWK 的抗原水平均正常。PK 的抗原降低。然而,对肾小球肾炎患者的凝血因子 XII 凝血活性(F XII:C)进行单独评估时发现,F XII:C 升高,且与血尿素氮值相关。在肾病的急性病程中,我们观察到 PK 的凝血活性非常高,随着患者病情稳定而恢复正常。我们 的结果表明,接触相凝血因子在某些肾病患者中表现异常。

相似文献

1
Clotting activities and antigen concentrations of contact factors in kidney disease.肾脏疾病中接触因子的凝血活性和抗原浓度
Thromb Res. 1985 Aug 15;39(4):475-84. doi: 10.1016/0049-3848(85)90171-9.
2
Prekallikrein, HMW-kininogen and factor XII in various disease states.不同疾病状态下的前激肽释放酶、高分子量激肽原和因子 XII 。
Thromb Res. 1983 Jul 15;31(2):351-64. doi: 10.1016/0049-3848(83)90336-5.
3
Dissemination of contact activation in plasma by plasma kallikrein.血浆激肽释放酶介导的血浆中接触激活的传播。
J Exp Med. 1980 Sep 1;152(3):608-19. doi: 10.1084/jem.152.3.608.
4
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.慢性肝病中的Hageman因子、高分子量激肽原和前激肽释放酶
J Clin Pathol. 1986 Sep;39(9):1003-5. doi: 10.1136/jcp.39.9.1003.
5
Factor XII, plasma prekallikrein, alpha 2-macroglobulin and C1-inhibitor levels in renal allograft recipients during immunosuppression with cyclosporin A--sequential measurements over four months in 17 patients.肾移植受者在接受环孢素A免疫抑制治疗期间的凝血因子Ⅻ、血浆前激肽释放酶、α2-巨球蛋白和C1抑制剂水平——17例患者四个月的连续测量结果
Thromb Haemost. 1987 Dec 18;58(4):993-7.
6
Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.大量先天性凝血缺陷和异常情况下的激肽释放酶和前激肽释放酶水平。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1982;109(4):644-54.
7
Genetic determinants of activity and antigen levels of contact system factors.接触系统因子活性和抗原水平的遗传决定因素。
J Thromb Haemost. 2019 Jan;17(1):157-168. doi: 10.1111/jth.14307. Epub 2018 Nov 2.
8
The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.前激肽释放酶和高分子量激肽原在硫酸脑苷脂及其他试剂对哈格曼因子(因子XII)的接触激活中的作用。
J Lab Clin Med. 1983 Oct;102(4):487-99.
9
Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.藤原特质中通过因子 XII 的接触激活异常:高分子量和低分子量激肽原均缺乏,且前激肽释放酶水平较低。
Tohoku J Exp Med. 1981 Jan;133(1):67-80. doi: 10.1620/tjem.133.67.
10
Improved methods to assay contact activation.检测接触激活的改进方法。
Adv Biosci. 1978 Jul 22;17:271-80.

引用本文的文献

1
FXII.十二因子
Blut. 1990 Nov;61(5):258-66. doi: 10.1007/BF01732874.